Association between sexual activity-related death and non-prescription use of phosphodiesterase type 5 inhibitors
Association between sexual activity-related death and non-prescription use of phosphodiesterase type 5 inhibitors
复制标题
DOI:
10.1016/j.legalmed.2020.101815
复制
发表时间:
2021-02-01
期刊:
影响因子:
1.5
通讯作者:
Iwase, Hirotaro
中科院分区:
文献类型:
--
作者:
Nagasawa, Sayaka;Saka, Kanju;Iwase, Hirotaro
In recent years, there has been an increase in the use of phosphodiesterase type 5 inhibitors (PDE5i) that are purchased from abroad without a doctor's diagnosis via the Internet or other means. We report six cases in which nonprescription use of PDE5i may have led to death. Among the four deceased individuals who were believed to have experienced sudden cardiac death, three (cases 1-3) had a history of cardiovascular disease, which is a contraindication, and the remaining case (case 4) involved combined use of multiple PDE5i. Sildenafil (0.063 mu g/mL, 0.087 mu g/mL) was detected in two of the four cases of sudden cardiac death. Tadalafil (0.096 mu g/mL) was detected in one of the remaining two cases, and tadalafil (0.197 mu g/mL) and vardenafil (0.011 mu g/mL) were detected in the other case. Sildenafil (0.032 mu g/mL), tadalafil (0.062 mu g/mL), and ethanol were detected in a traffic accident case with a history of contraindications. In a case of asphyxiation by vomit aspiration, autopsy showed 90% stenosis in the anterior descending branch of the coronary artery, and sildenafil (0.063 mu g/mL) was detected. To the best of our knowledge, this is the first report of postmortem blood levels of tadalafil and vardenafil likely contributing to the cause of death. Despite all the warnings about the dangers of using PDE5 inhibitors, cases of PDE5i contributing to death are still identified during autopsies. Therefore, raising public awareness of the risks of the risks associated with the imported drug use by individuals is necessary.